Dear Colleagues,
Greetings.
The Boston Chapter of the American Statistical Association (BCASA) invites you all to attend the 2024 Boston Pharmaceutical Statistics Symposium on Thursday, October 31 – Friday, November 1, 2024, at Sanofi, Cambridge Crossing - 450 Water St, Cambridge, MA.
As an annual event, the Boston Pharmaceutical Statistics Symposium provides a unique venue for sharing statistical applications and research in the biotech-pharma industry and building connections among all colleagues of the Greater Boston area engaged in the industry statistical practice. We welcome the participation of industry statisticians, academic researchers, university students, and any professionals interested in pharmaceutical statistical topics.
The 2024 Boston Pharmaceutical Statistics Symposium features a full-day event of engaging activities, including a series of invited talks, a lightning talk session, a poster session, and networking opportunities. Two short courses will be offered on October 31, one day before the symposium. These two carefully curated short courses, focusing on Causal inference and AI/ML in deriving RWE from the analysis of RWD and AI/ML for Clinical Trials and Humanized AI for Future Healthcare, offer an opportunity to learn from a leading expert.
Visit our WEBSITE for more information.
All participants must register by Wednesday, October 23. The registration fee for the symposium covers a light breakfast, lunch, afternoon snacks, and symposium materials. The registration fee for the short course covers snacks and short course materials.
Register Here for Symposium Main Event (Day 2)!
Register Here for Short Courses (Day 1, In-Person)!
Register Here for Short Courses (Day 1, Virtual)!
Our speakers
Keynote speaker:
- Statistical Boom: Opportunities for a Statistician in an Era of Quantitative Medicines Development by Margaret Gamalo, Vice President and Statistics Head for Inflammation and Immunology, Global Product Development, Pfizer
Invited short course instructors:
- Causal inference and AI/ML in deriving RWE from the analysis of RWD by Yixin Fang, Director of Medical Affairs and Health Technology Assessment Statistics and a research fellow of AbbVie Community of Science, AbbVie
- AI/ML for Clinical Trials and Humanized AI for Future Healthcare by Mark Chang, Founder, Adjunct Professor, AGInception, Boston University
Invited speakers:
- Optimal Priors for the Discounting Parameter of the Normalized Power Prior by Joseph Ibrahim, Alumni Distinguished Professor of Biostatistics and the Director of the Biostatistics Core at Lineberger Comprehensive Cancer Center, UNC
- Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing by Veronica Bunn, Associate Director in Oncology statistics, Takeda
- AI-Generated R Functions Integrated with Proprietary Software for Clinical Trial Simulation by J. Kyle Wathen, Vice President, Scientific Strategy & Product Innovation, Cytel
- Driving Efficiency of Clinical Drug Supply Chains Management in Adaptive Clinical Trials by Zoe Hua, a director biostatistician at Servier Bio-Innovation in late stage clinical development for oncology therapies, Servier
- Using Digital Innovation in Clinical Trials: Function of Advanced Modelling and Data Science by Zhaoling Meng, Associate Vice President, Global Head of Clinical Modeling and Evidence Integration in Evidence Generation and Decision Science, R&D, Sanofi
- Pragmatic Clinical Trials: Future Directions and Design Considerations by Cynthia Hau, Statistician for the Veterans Affairs (VA) Cooperative Studies Program, Boston Coordinating Center
- Practical Steps Toward Model-informed Drug Development using Causal Diagrams by James Rogers, Vice President of Statistics in the Quantitative Sciences Business Unit, Metrum Research Group
- Title TBD by Issa Dahabreh, Associate Professor of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard
Our Sponsors
The Boston Chapter invites you to be a sponsor of the 2024 Boston Pharmaceutical Statistics Symposium. Please contact Wenting Cheng (chengwt@umich.edu, Co-chair of the 2024 Boston Pharmaceutical Statistics Symposium, President of the Boston Chapter) and Zhaoyang Teng (zhaoyang.teng@servier.com, Co-chair of the 2024 Boston Pharmaceutical Statistics Symposium) if you have any questions.
Thank you to our sponsors which have already been confirmed: Sanofi (Venue Sponsor); Novo Nordisk (Platinum Sponsor); BioPier (Silver Sponsor).
*******************************************
2024 Boston Pharmaceutical Statistics Symposium Scientific Committee
Symposium Co-Chair and President of Boston Chapter of ASA
Wenting Cheng, Biogen
Symposium Co-Chair and Chair of Speakers and Short Course Subcommittee
Zhaoyang Teng, Servier
Symposium Vice-Chair and Venue Host
Gautier Paux, Sanofi
Symposium Vice-Chair and Chair of Poster and Lightning Talks Subcommittee
Xihao Li, UNC-Chapel Hill
Symposium Past-Chair and In-charge of student volunteers, Boston local liaison
Kristin Baltrusaitis, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health
Chair of Communication Subcommittee and Webmaster of Boston Chapter of ASA
Kush Kapur, argenx, Inc.
Symposium Scientific Committee Members
Hailu Chen, Alkermes
Brooks Clark, Cytel
Jinghui Dong, Kite, Gilead Science
Jimmy Efird, VA CSPCC - Boston
Lei Gao, Moderna
Kosalaram Goteti, EMD Serono & ISOP (SxP-SIG)
Larry Han, Northeastern University
Ina Jazic, Vertex
Jun Ke, Astrazeneca
Fotios Kokkotos, Boston University
Maria Kudela, Pfizer
Hrishikesh Kulkarni, Alexion
Qing Li, Morphosys
Jianchang Lin, Takeda
Charles Liu, Gilead
Jameson Luks, MaxisIT
Jianing Wang, Massachusetts General Hospital
Ting Wang, Biogen
Tu Xu, Novo Nordisk
Disa Yu, Sanofi
Weidong Zhang, Sana Biotechnology
------------------------------
Best,
Wenting
------------------------------